FORMA Therapeutics has successfully completed a critical objective under its strategic collaboration agreement with Celgene, triggering an undisclosed payment from Celgene
FORMA Therapeutics, a clinical-stage and fully integrated discovery and development company, has announced the achievement of a clinical development milestone in their alliance with Boehringer Ingelheim (BI).